Ceres Ventures, Inc.

Indentures Filter

EX-4.5
from 10-Q 8 pages Ceres Ventures, Inc. Form of Series E Stock Purchase Warrant
12/34/56
EX-4.4
from 10-Q 8 pages Ceres Ventures, Inc. Form of Series D Warrant
12/34/56
EX-4.1
from 10-Q 22 pages Subscription Agreement by and Between
12/34/56
EX-4.2
from S-1/A 10 pages Series B Common Stock Purchase Warrant Phytomedical Technologies, Inc
12/34/56
EX-4.1
from S-1/A 4 pages Phytomedicaltechnologies, Inc. Subscription Agreement the Offer and Sale of Up to 200,000,000 Units in Accordance With the Prospectus Dated <>, 2010 Offering Price - $0.01per Unit
12/34/56
EX-4.2
from S-1 10 pages Series B Common Stock Purchase Warrant Phytomedical Technologies, Inc
12/34/56
EX-4.1
from S-1 4 pages Phytomedicaltechnologies, Inc. Subscription Agreement the Offer and Sale of Up to 200,000,000 Units in Accordance With the Prospectus Dated <>, 2010 Offering Price - $0.01per Unit
12/34/56
EX-4.7
from SB-2 12 pages Placement Agent Warrant
12/34/56
EX-4.7
from SB-2/A 12 pages Placement Agent Warrant
12/34/56
EX-4.6
from SB-2/A 12 pages Form of Warrant
12/34/56
EX-4.6
from SB-2 12 pages Form of Warrant
12/34/56
EX-4.5
from SB-2/A 30 pages Section Certain Definitions
12/34/56
EX-4.5
from SB-2 30 pages Section Certain Definitions
12/34/56
EX-4.4
from SB-2 20 pages The Securities to Which This Afreement Relates Have Not Been Registered Under the United States Securities Act of 1933, as Amended (The “1933 Act”) and the Rules and Regulations Promulgated Thereunder and May Not Be Transfered or Sold Except Pursuant to an Effective Registration Statement as to Such Securities or Under an Applicable Exemption From, the Registration Requirements of the 1933 Act, and Apllicable State Securities Laws, in Each Case as Evidence by an Opinion of Counsel Acceptable to the Company. This Subscription Agreement Is Made as of September 11, 2007 by and Between the Undersigned Subscriber (The “Subscriber”) and Phytomedical Technologies, Inc., a Nevada Corporation (The “Company”)
12/34/56
EX-4.4
from SB-2/A 20 pages The Securities to Which This Afreement Relates Have Not Been Registered Under the United States Securities Act of 1933, as Amended (The “1933 Act”) and the Rules and Regulations Promulgated Thereunder and May Not Be Transfered or Sold Except Pursuant to an Effective Registration Statement as to Such Securities or Under an Applicable Exemption From, the Registration Requirements of the 1933 Act, and Apllicable State Securities Laws, in Each Case as Evidence by an Opinion of Counsel Acceptable to the Company. This Subscription Agreement Is Made as of September 11, 2007 by and Between the Undersigned Subscriber (The “Subscriber”) and Phytomedical Technologies, Inc., a Nevada Corporation (The “Company”)
12/34/56
EX-4
from DEFR14A ~50 pages Incentive Stock Plan
12/34/56
EX-4
from DEF 14A ~50 pages Incentive Stock Plan
12/34/56
EX-4
from PRE 14A ~50 pages Incentive Stock Plan
12/34/56
EX-4.2
from S-8 ~20 pages 1999 Incentive Stock Option Plan
12/34/56
EX-4.1
from S-8 ~20 pages 1998 Incentive Stock Option Plan
12/34/56